ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,993Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 90

$2.31M Total Retail Price of All Prescriptions

Rank: 1 out of 90

682 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 682 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

15% of this provider’s 682 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 19,453 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $115 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 1,859 1,187 1 1
METOPROLOL TARTRATE 965 641 2 7
SIMVASTATIN 950 710 3 12
HYDRALAZINE HCL 879 500 10 4 11
LOSARTAN POTASSIUM 739 538 5 17
LISINOPRIL 736 397 6 3
PRAVASTATIN SODIUM 709 462 7 20
PROSOL 698 474 10 8 24
RANITIDINE HCL 642 396 9 28
CARVEDILOL 642 427 9 6
CLONIDINE HCL 594 234 11 9
FUROSEMIDE 580 364 12 2
CALCITRIOL 577 461 13 14
DIOVAN 525 363 14 18
ATORVASTATIN CALCIUM 514 422 15 23
RENVELA 505 179 16 4
OMEPRAZOLE 483 332 17 15
ALLOPURINOL 417 299 18 13
TRAMADOL HCL 413 232 19 26
SPIRONOLACTONE 397 258 20 31
GABAPENTIN 396 227 21 22
ISOSORBIDE MONONITRATE ER 375 282 22 33
DOXAZOSIN MESYLATE 374 173 23 16
LEVOTHYROXINE SODIUM 365 317 24 21
METFORMIN HCL 338 214 25 42
GLIMEPIRIDE 311 224 26 57
WARFARIN SODIUM 283 204 27 34
SENSIPAR 269 118 28 5
HYDROCODONE-ACETAMINOPHEN 269 194 S3 28 10
AMITRIPTYLINE HCL 260 173 R 30 56
ATENOLOL 200 158 31 37
TERAZOSIN HCL 193 112 32 74
MINOXIDIL 187 92 10 33 32
SERTRALINE HCL 184 100 34 75
POLYETHYLENE GLYCOL 3350 173 110 35 75
AMLODIPINE BESYLATE-BENAZEPRIL 171 128 36 43
INSULIN SYRINGE 168 77 37 64
METOPROLOL SUCCINATE 162 133 38 40
LANTUS 161 93 39 65
PREDNISONE 159 101 40 27
AZITHROMYCIN 156 93 41 60
BENICAR 154 95 42 95
HYDROCHLOROTHIAZIDE 153 143 43 35
PANTOPRAZOLE SODIUM 152 95 44 48
CALCIUM ACETATE 151 88 45 8
DONEPEZIL HCL 150 150 46 97
ZETIA 147 106 47 98
FLUOXETINE HCL 146 83 48 79
BENAZEPRIL HCL 145 109 49 25
SPIRIVA 143 110 50 100
CLOPIDOGREL 143 90 50 47
TAMSULOSIN HCL 137 96 52 62
CRESTOR 131 86 53 44
CYCLOBENZAPRINE HCL 131 79 R 53 72
DIOVAN HCT 128 115 55 58
NEXIUM 123 63 56 38
FAMOTIDINE 122 78 57 36
POTASSIUM CHLORIDE 116 97 58 54
TRAZODONE HCL 113 60 59 50
HYDROXYZINE HCL 111 32 R 60 88
NIFEDIPINE ER 110 68 61 19
LOSARTAN-HYDROCHLOROTHIAZIDE 105 56 62 83
COMBIVENT 102 54 63 109
LIPITOR 101 63 64 93
TRAMADOL HCL-ACETAMINOPHEN 101 85 64 78
PLAVIX 100 74 66 68
METOCLOPRAMIDE HCL 93 48 67 59
LABETALOL HCL 93 12 67 39
ESCITALOPRAM OXALATE 92 62 69 94
EXFORGE 92 73 69 81
ZOLPIDEM TARTRATE 90 41 71 30
VERAPAMIL HCL 89 70 72 111
DEXTROSE IN WATER 88 88 73 84
LOVASTATIN 87 45 74 49
NAPROXEN 85 58 75 112
COLCRYS 85 60 75 46
DILTIAZEM 24HR ER 82 42 77 90
LYRICA 82 41 77 103
DIPHENOXYLATE-ATROPINE 78 28 79 104
OXYBUTYNIN CHLORIDE ER 78 55 79 114
FINASTERIDE 77 73 81 115
NIASPAN 74 55 82 117
DOXYCYCLINE HYCLATE 74 41 82 117
PROCRIT 73 53 84 120
INTRALIPID 73 73 84 96
ENALAPRIL MALEATE 72 32 86 98
ISOSORBIDE DINITRATE 72 63 86 122
TEKTURNA 71 42 88 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 60 89 63
ADVAIR DISKUS 70 50 89 124
ALENDRONATE SODIUM 69 59 91 100
CLOTRIMAZOLE-BETAMETHASONE 67 33 92 125
GLYBURIDE 67 59 R 92 125
ULORIC 66 40 94 92
MICARDIS 66 32 94 128
MICARDIS HCT 66 35 94 128
PROMETHAZINE HCL 64 40 R 97 61
RISPERIDONE 63 29 98 105
VERAPAMIL ER 62 48 99 106
CEFUROXIME 62 39 99 133
ROPINIROLE HCL 61 45 101 135
NOVOLOG 61 37 101 135
GLYBURIDE-METFORMIN HCL 61 44 R 101 135
NOVOLOG MIX 70-30 61 21 101 135
CIPROFLOXACIN HCL 59 40 105 87
HUMALOG MIX 75-25 57 21 106 141
DIVALPROEX SODIUM 57 47 106 141
NORTRIPTYLINE HCL 57 35 106 141
SINGULAIR 56 23 109 144
JANUVIA 55 32 110 85
PHENYTOIN SODIUM EXTENDED 55 29 110 147
KLOR-CON 10 55 41 110 147
MEGESTROL ACETATE 54 38 R 113 79
NOVOLOG MIX 70-30 FLEXPEN 54 45 113 149
CYPROHEPTADINE HCL 53 13 R 115 152
CILOSTAZOL 53 46 115 152
PEN NEEDLE 52 42 117 106
SYMBICORT 51 18 118 156
BENICAR HCT 51 32 118 156
LEVOFLOXACIN 51 32 118 156
SIMCOR 50 39 121 159
MECLIZINE HCL 50 48 121 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.